Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference

Rhea-AI Summary

Generation Bio (Nasdaq: GBIO), a biotechnology company focused on developing treatments for T cell-driven autoimmune diseases, has announced that its President and CEO, Geoff McDonough, M.D., will deliver a presentation at the upcoming Jefferies Global Healthcare Conference. The presentation is scheduled for Wednesday, June 4th, 2025, at 8:10 a.m. ET.

Interested parties can access a live webcast of the presentation through the investor section of Generation Bio's website at investors.generationbio.com. A replay of the presentation will remain available on the website for 30 days after the event.

News Market Reaction – GBIO

-1.11%

-1.11% Session move

In the trading session that priced this news, GBIO declined 1.11%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 4^th at 8:10 a.m. ET.

A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.  
  
About Generation Bio   

Generation Bio is a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases. The company is developing redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells, which erroneously recognize and attack the body’s own tissues, causing autoimmune diseases. Generation Bio’s innovative approach leverages cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) to T cells. This combination of selective delivery and an intracellular, genetically precise mechanism of target engagement could unlock a series of high-value, historically undruggable disease-driving genes in autoimmunity.

For more information, please visit www.generationbio.com.

Investors and Media Contact  
Maren Killackey  
Generation Bio  
mkillackey@generationbio.com  
857-371-4638  
  

FAQ

When is Generation Bio (GBIO) presenting at the Jefferies Global Healthcare Conference 2025?

Generation Bio will present at the Jefferies Global Healthcare Conference on Wednesday, June 4th, 2025, at 8:10 a.m. ET.

Who will represent Generation Bio (GBIO) at the Jefferies Healthcare Conference 2025?

Geoff McDonough, M.D., President and CEO of Generation Bio, will present at the conference.

How can I watch Generation Bio's (GBIO) presentation at the Jefferies Conference?

The presentation can be viewed via live webcast on Generation Bio's investor website at investors.generationbio.com. A replay will be available for 30 days after the event.

What is Generation Bio's (GBIO) main focus as a company?

Generation Bio is a biotechnology company working to develop treatments for people living with T cell-driven autoimmune diseases.